Sign in

CIK 0001422142

  • Non-accelerated filer
  • Smaller reporting company

Whitehawk Therapeutics, Inc.

Sign in to watch
Ticker
WHWK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
611547850
Phone
+1 551-321-2234
Business address
2 HEADQUARTERS PLAZA, EAST BUILDING, 11TH FLOOR, MORRISTOWN, NJ, 07960
Former names
Aadi Bioscience, Inc., Aerpio Pharmaceuticals, Inc., ZETA ACQUISITION CORP II
  1. 4 Open-market buy Director bought 63,818 shares at an average $2.35 ($150,290)
  2. 4 Open-market buy Director bought 60,000 shares at an average $2.12 ($127,462)
  3. 4 Open-market buy Director bought 60,000 shares at an average $1.80 ($108,110)
  4. 4 Open-market buy Director bought 60,000 shares at an average $1.74 ($104,134)
  5. 4 Open-market buy Director bought 60,000 shares at an average $1.92 ($115,224)
  6. 4 Open-market buy Director bought 60,000 shares at an average $2.02 ($121,340)
  7. 4 Open-market buy Director bought 60,000 shares at an average $2.12 ($127,242)
  8. 4 Open-market buy Director bought 60,000 shares at an average $2.09 ($125,352)
  9. 4 Open-market buy Director bought 60,000 shares at an average $1.98 ($118,524)
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market buy Chief Executive Officer bought 31,967 shares at an average $2.01 ($64,136)
  12. 4 Returned to the company Director returned 1,603,526 shares (to the company)
  13. 4 Open-market sale 10% owner sold 5,300 shares at $3.90 ($20,670)
  14. 4 Open-market buy Director bought 777,500 shares at $3.85 ($2,993,375)
  15. 4 Open-market buy Director bought 777,500 shares at $3.85 ($2,993,375)
  16. 4 Open-market buy Director bought 1,818,182 shares at $3.85 ($7,000,001)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 11 of 14 · 263 filings